Advertisement

Improved Ventilation by Re-aeration of Atelectatic Regions with Exogenous Surfactant in Acute Respiratory Failure

  • D. Gommers
  • B. Lachmann
Conference paper

Abstract

Improved oxygenation, decreased ventilator requirements, and increased survival have been reported after tracheal administration of surfactant in premature infants with respiratory distress syndrome (RDS) [1]. It seems reasonable to assume that such improvement in gas exchange is caused by an immediate improvement in lung volumes and lung mechanics. However, studies in which respiratory compliance was calculated from tidal volumes (dynamic compliance) during mechanical ventilation in surfactant-treated infants did not show any immediate changes [2–4]. To understand the mechanisms behind the improved oxygenation after tracheal surfactant instillation, we first describe the normal function of the pulmonary surfactant system, then discuss the immediate effects of exogenous surfactant instillation on lung volume and lung mechanics by reviewing experimental and clinical findings.

Keywords

Respiratory Distress Syndrome Lung Volume Acute Respiratory Failure Functional Residual Capacity Adult Respiratory Distress Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jobe AH (1993) Pulmonary surfactant therapy. N Engl J Med 328:861–868PubMedCrossRefGoogle Scholar
  2. 2.
    Goldsmith LS, Greenspan JS, Rubenstein SD et al (1991) Immediate improvement in lung volume after exogenous surfactant in lung volume after exogenous surfactant: alveolar recruitment versus increased distension. J Pediatr 119:424–428PubMedCrossRefGoogle Scholar
  3. 3.
    Farstad T, Bratlid D (1995) Pulmonary effects after treatment in premature infants with severe respiratory distress syndrome. Biol Neonate 68:246–253PubMedCrossRefGoogle Scholar
  4. 4.
    Cotton RB, Olsson T, Law AB et al (1993) The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease. Pediatr Res 1993:495–501CrossRefGoogle Scholar
  5. 5.
    Johansson J, Curstedt T, Robertson B (1994) The proteins of the surfactant system. Eur Respir J 7:372–391PubMedCrossRefGoogle Scholar
  6. 6.
    Bos JAH, Lachmann B (1992) Effects of artificial ventilation on surfactant function. In: Rügheimer E (ed) New aspects on respiratory failure. Springer, Berlin Heidelberg New York, pp 194–208CrossRefGoogle Scholar
  7. 7.
    Lachmann B (1987) The role of pulmonary surfactant in the pathogenesis and therapy of ARDS. In: Vincent JL (ed) Update in intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 123–134Google Scholar
  8. 8.
    Lachmann B (1985) Possible function of bronchial surfactant. Eur J Respir Dis 67:46–61Google Scholar
  9. 9.
    van Iwaarden F (1992) Surfactant and the pulmonary defense system. In: Robertson B, Van Golde LMG, Batenburg JJ (eds) Pulmonary surfactant. Elsevier, Amsterdam, pp 215–253Google Scholar
  10. 10.
    Hein T, Lachmann B, Armbruster S et al (1987) Pulmonary surfactant inhibits the cardiovascular effects of platelet-activating factor (PAF), 5-hydroxytryptamine (5-HT) and angiotensin II. Am Rev Respir Dis 135[Suppl]:A506Google Scholar
  11. 11.
    So KL, Gommers D, Lachmann B (1993) Bronchoalveolar surfactant system and intratracheal adrenalin. Lancet 341:120–121PubMedCrossRefGoogle Scholar
  12. 12.
    Seeger W, Gunther A, Walmrath HD et al (1993) Alveolar surfactant and adult respiratory distress syndrome. Clin Investigation 71:177–190Google Scholar
  13. 13.
    Lewis JF, Jobe AH (1993) Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 147:218–233PubMedCrossRefGoogle Scholar
  14. 14.
    Fujiwara T, Robertson B (1992) Pharmacology of exogenous surfactant In: Robertson B, Van Golde LMG, Batenburg JJ (eds) Pulmonary surfactant: from molecular biology to clinical practice. Elsevier, Amsterdam, pp 561–592Google Scholar
  15. 15.
    Seeger W, Grube C, Günther A et al (1993) Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Resp J 6:971–977Google Scholar
  16. 16.
    Soll RF et al (1996) A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatr 97:1–6Google Scholar
  17. 17.
    Hudak ML et al (1996) A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome. J Pediatr 128:396–406PubMedCrossRefGoogle Scholar
  18. 18.
    Gommers D, Lachmann B (1995) Surfactant therapy in the adult patient. Current Opinion Crit Care 1:57–61CrossRefGoogle Scholar
  19. 19.
    Jobe A, Ikegami M (1987) Surfactant for treatment of respiratory distress syndrome. Am Rev Respir Dis 136:1256–1275PubMedCrossRefGoogle Scholar
  20. 20.
    Hedenstierna G (1993) The recording of FRC — is it of importance and can it be made simple? Intensive Care Med 19:365–366PubMedCrossRefGoogle Scholar
  21. 21.
    Couser RJ, Ferrara TB, Ebert J et al (1990) Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease. J Pediatr 116:119–124PubMedCrossRefGoogle Scholar
  22. 22.
    Edberg KE, Ekström-Jodal B, Hallman M et al (1990) Immediate effects on lung function of instilled human surfactant in mechanically ventilated newborn infants with IRDS. Acta Paediatr Scand 79:750–755PubMedCrossRefGoogle Scholar
  23. 23.
    Bhat R, Dziedzic K, Bhatani V et al (1990) Effect of single dose surfactant on pulmonary function. Crit Care Med 18:590–595PubMedCrossRefGoogle Scholar
  24. 24.
    Davis JM, Veness-Meehan K, Notter RH et al (1988) Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome. N Eng J Med 319:476–479CrossRefGoogle Scholar
  25. 25.
    Gommers D, Vilstrup C, Bos JAH et al (1993) Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone. Crit Care Med 21:567–574PubMedCrossRefGoogle Scholar
  26. 26.
    Schaffer TH, Koen PA, Moskowitz GD et al (1978) Positive End Expiratory Pressure: Effects on lung mechanics of premature lambs. Biol Neonate 34:1–10CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1997

Authors and Affiliations

  • D. Gommers
  • B. Lachmann

There are no affiliations available

Personalised recommendations